Artiva Biotherapeutics, Inc. (ARTV) vs ClearPoint Neuro, Inc. (CLPT)
A side-by-side comparison of Artiva Biotherapeutics, Inc. and ClearPoint Neuro, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARTV
Artiva Biotherapeutics, Inc.
$7.29HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
CLPT
ClearPoint Neuro, Inc.
$10.76HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — ARTV vs CLPT
growth of $100 · dividends reinvested · last 2yARTV -40.6% (-22.9%/yr)CLPT +58.9% (+26.1%/yr)CLPT compounded faster over this window
ARTV CLPT
ARTV vs CLPT: by the numbers
- •ARTV is the larger company ($356M vs $323M market cap).
- •Both run net losses; ARTV's is the smaller (0.00% vs -81.76% net margin).
Metrics side by side
Valuation
| Metric | ARTV | CLPT |
|---|---|---|
| P/S ratio | N/A | 7.63 |
| P/B ratio | 1.03 | 29.95 |
Profitability
| Metric | ARTV | CLPT |
|---|---|---|
| Gross margin | 0.00% | 62.61% |
| Operating margin | 0.00% | -65.36% |
| Net margin | 0.00% | -81.76% |
| ROE | -26.14% | -320.77% |
| ROIC | -27.16% | -40.51% |
Growth (annualized)
| Metric | ARTV | CLPT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 23.57% |
| Total return CAGR (5Y) | N/A | -7.65% |
Go deeper
Dig into the metrics
Artiva Biotherapeutics ROEClearPoint Neuro ROEArtiva Biotherapeutics operating marginClearPoint Neuro operating marginArtiva Biotherapeutics revenue growthClearPoint Neuro revenue growthArtiva Biotherapeutics free cash flowClearPoint Neuro free cash flow
Artiva Biotherapeutics & ClearPoint Neuro appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.